118 related articles for article (PubMed ID: 3476367)
1. Contribution of clonogenic leukemic cell characteristics to therapy outcome in patients with acute myeloblastic leukemia.
Aul C; Heyll A
Haematol Blood Transfus; 1987; 30():356-60. PubMed ID: 3476367
[No Abstract] [Full Text] [Related]
2. Prediction of induction and duration of complete remission in acute myelogenous leukemia: value of clonogenic cell properties.
Zittoun R; Marie JP; Brilhante D; Delmer A
Haematol Blood Transfus; 1987; 30():45-9. PubMed ID: 3476378
[No Abstract] [Full Text] [Related]
3. [Cure of acute myeloblastic leukemia in a child with Down syndrome and tetralogy of Fallot].
Balcar-Boroń A; Nowaczyk-Michalak A; Graduszewska-Czerebiej K
Wiad Lek; 1992 Mar; 45(5-6):220-3. PubMed ID: 1455866
[No Abstract] [Full Text] [Related]
4. Association between the secondary colony-plating efficiency of blast progenitors and the remission induction outcome of acute myeloblastic leukemia patients.
Nara N
Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1624-9. PubMed ID: 3247826
[No Abstract] [Full Text] [Related]
5. Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells.
Gustavsson A; Olofsson T
Cancer Res; 1984 Oct; 44(10):4648-52. PubMed ID: 6590116
[TBL] [Abstract][Full Text] [Related]
6. Remission induction with cytarabine and daunorubicin with or without 6-thioguanine in adult patients with acute myelocytic leukemia.
Nowrousian MR; Pfeiffer R; Schaefer UW; Osieka R; Niederle N; Anders C; Schmidt CG
Haematol Blood Transfus; 1987; 30():352-5. PubMed ID: 3305206
[No Abstract] [Full Text] [Related]
7. [Comparative analysis of 3 therapeutic regimens based on the combination of an anthracycline and cytosine arabinoside for remission induction in myeloblastic leukemia].
Sanz MA; Lorenzo JI; Sanz GF; Martín Aragonés G; Rafecas FJ; Martínez JA; Gomis F
Sangre (Barc); 1988 Dec; 33(6):497-504. PubMed ID: 3247626
[No Abstract] [Full Text] [Related]
8. Cellular pharmacokinetics of daunomycin in human leukemic blasts in vitro and in vivo.
Scheulen ME; Kramer B; Skorzec M; Reich WK
Haematol Blood Transfus; 1990; 33():122-8. PubMed ID: 2323624
[No Abstract] [Full Text] [Related]
9. Acute myeloblastic leukemia in adults.
Kasthuri AS; Jaiprakash MP; Anand KP; Kumar R
J Assoc Physicians India; 1995 Feb; 43(2):108-10. PubMed ID: 9282674
[No Abstract] [Full Text] [Related]
10. Chemotherapy of adult acute myeloid leukaemia.
Suri R; Kueh YK; Han P; Tan YO
Ann Acad Med Singap; 1990 Mar; 19(2):175-7. PubMed ID: 2346291
[TBL] [Abstract][Full Text] [Related]
11. Oscillations of marrow culture growth in acute myeloid leukemia during remission induction and remission.
Gustavsson A; Olofsson T; Olsson I
Acta Haematol; 1979; 62(5-6):241-6. PubMed ID: 121664
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy with DATV regimen in treatment of adult acute nonlymphocytic leukemia.
Lou FD; Zhou Q; Liu HC; Meng FY; Wang YZ
Chin Med J (Engl); 1993 Nov; 106(11):876-8. PubMed ID: 8143502
[No Abstract] [Full Text] [Related]
13. Etoposide in remission induction of adult acute myeloid leukemia.
Leoni F; Ciolli S; Patriarchi S; Morfini M; Rossi Ferrini P
Acta Haematol; 1990; 83(2):82-5. PubMed ID: 2106200
[TBL] [Abstract][Full Text] [Related]
14. [DCTP(II) combination chemotherapy of adult acute nonlymphocytic leukemia].
Kobayashi T; Ogawa M; Kuraishi Y; Nagata T; Aiba K; Nakamura T; Usui N; Yamazaki H; Ichiba K; Isogai Y
Nihon Ketsueki Gakkai Zasshi; 1988 Aug; 51(5):855-63. PubMed ID: 3206983
[No Abstract] [Full Text] [Related]
15. Non-cardiotoxic anthracycline regimens in the treatment of acute myeloblastic leukaemia.
Boughton BJ; Franklin IM; Apperley J; Knight D
Br J Haematol; 1984 Oct; 58(2):378-80. PubMed ID: 6591946
[No Abstract] [Full Text] [Related]
16. Therapy of acute myelogenous leukemia in adults.
Petti MC; Broccia G; Caronia F; Di Raimondo F; Fioritoni G; Ladogana S; Leone G; Liso V; Musso M; Neri A
Haematol Blood Transfus; 1990; 33():249-53. PubMed ID: 2182417
[No Abstract] [Full Text] [Related]
17. Second long-term remission achieved with low-dose Ara-C in children with relapsed acute nonlymphoblastic leukemia.
Miniero R; Saracco P; Cordero di Montezemolo L; Fiandino G; Comelli A; Madon E
Pediatr Hematol Oncol; 1987; 4(3):273-6. PubMed ID: 3152932
[No Abstract] [Full Text] [Related]
18. Acute nonlymphocytic leukemia in adults: results obtained with TAD remission induction therapy.
Witteveen EO; Verdonck LF; Nieuwenhuis HK; Dekker AW
Haematol Blood Transfus; 1990; 33():309-13. PubMed ID: 2323635
[No Abstract] [Full Text] [Related]
19. Influence of daunorubicin and cytarabine sequencing on the outcome of therapy in acute myelogenous leukemia: a randomized trial.
Archimbaud E; Fiere D; Treille-Ritouet D; Adeleine P; Guyotat D; Sebban C; Vuvan H; Viala JJ
Cancer Treat Rep; 1987 Jun; 71(6):571-4. PubMed ID: 3555788
[TBL] [Abstract][Full Text] [Related]
20. The ninth British Medical Research Council trial for the treatment of acute myeloid leukaemia.
Rees JK; Gray R; Hayhoe FG
Haematol Blood Transfus; 1987; 30():35-7. PubMed ID: 2442075
[No Abstract] [Full Text] [Related]
[Next] [New Search]